57
Google's AI genome system evaluates every possible one-base change
Google's AlphaGenome AI system predicts functional effects of non-coding DNA variants in humans and mice.
Google's AlphaGenome AI system evaluates genomic sequences to predict gene expression, transcription factor binding, chromatin accessibility, splice site usage, and related genomic features. The system is currently limited to human and mouse sequences and a limited set of well-studied cell types, but its predictions generally match or exceed specialized software tools. Researchers can use it to assess whether non-coding variants are likely significant and generate hypotheses about their function.
42
42
60
42
60
60
Google’s Atlas of the human genome could pave the way for new treatments
Google DeepMind launches AlphaGenome Atlas, a catalog of predicted molecular effects for roughly nine billion single-letter DNA changes across the human genome.
Google DeepMind unveiled AlphaGenome Atlas, a roughly 1-petabyte dataset predicting how each of about nine billion possible single-nucleotide variants affects molecular biology, including non-coding regions that regulate gene behavior. It builds on the AlphaGenome model released in 2025 and adds a Variant Impact Score (AVI) to help researchers rank variants. The catalog is available for noncommercial research via a web portal, the Antigravity platform, and the AlphaGenome interface, with commercial access on Google Cloud planned.
50
30
55
30
42
55
30
CISA Warned About Critical Vulnerabilities in Illumina's DNA Sequencing Devices
60
30
42
55
30
42
30
30
30
30
57
45
45
30
42
30
42
42
57
30
55
55
30
30
55
30